nach oben

Somnologie

Erschienen in:

01.12.2022 | Polyzystisches Ovarialsyndrom | CME

Schlafbezogene Atmungsstörungen und Gynäkologie – Teil 2

Therapie, Sonderformen von SBAS bei Frauen, Auswirkungen von SBAS auf die Sexualfunktion bei Frauen, Syndrom der polyzystischen Ovarien

verfasst von: Prof. Dr. med. M. Orth, K. Rasche

Erschienen in: Somnologie | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

Schlafmedizin trifft Gynäkologie – ist das „l’art pour l’art“, also Kunst um der Kunst willen? Nein. In Teil 1 (Somnologie 3/2022) wurden Pathophysiologie, Prävalenz und geschlechtsspezifische Besonderheiten schlafbezogener Atmungsstörungen (SBAS) bei Frauen erörtert, in Teil 2 sind es klinische Aspekte von SBAS bei Frauen. Obwohl die Produktion weiblicher Sexualhormone mit dem Alter abnimmt und einen wichtigen Faktor für den Anstieg der SBAS-Prävalenz bei peri- bzw. postmenopausalen Frauen darstellt, ist die externe Hormonsubstitution keine Therapieoption. Die Atmungsstörung „upper airway resistance syndrome“ (UARS) ist bei Frauen häufiger als bei Männern. Die Diagnose eines UARS kann nur polysomnographisch gestellt werden. SBAS führen bei Frauen zu erheblichen Störungen der Sexualfunktion. Das Syndrom der polyzystischen Ovarien (PCOS) geht bereits bei heranwachsenden Mädchen mit SBAS einher. Das PCOS bedarf der intensiven Zusammenarbeit von Gynäkologen, Endokrinologen und Schlafmedizinern.

Nur mit Berechtigung zugänglich

Popovic RM, White DP (1995) Influence of gender on waking genioglossal electromyogram and upper airway resistance. Am J Respir Crit Care Med 152:725–731. https://doi.org/10.1164/ajrccm.152.2.7633734CrossRef

Popovic RM, White DP (1985) Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol 84:1055–1062. https://doi.org/10.1152/jappl.1998.84.3.1055CrossRef

Prentice RL, Anderson GL (2008) The women’s health initiative: lessons learned. Annu Rev Public Health 29:131–150CrossRef

AWMF, Leitlinie S3, Peri- und Postmenopause, Diagnostik und Interventionen

Block AJ, Wynne JW, Boysen PG et al (1981) Menopause, medroxyprogesterone and breathing during sleep. Am J Med 70(3):506–510. https://doi.org/10.1016/0002-9343(81)90572-6CrossRef

D’Ambrosio C, Stachenfeld NS, Pisani M et al (2005) Sleep, breathing, and menopause: the effect of fluctuating estrogen and progesterone on sleep and breathing in women. Gend Med 2(4):238–245. https://doi.org/10.1016/s1550-8579(05)80053-1CrossRef

Bixler EO, Vgontzas AN, Lin HM et al (2001) Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 163:608–613. https://doi.org/10.1164/ajrccm.163.3.9911064CrossRef

Polo-Kantola P, Rauhala E, Helenius H et al (2003) Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol 102(1):68–75. https://doi.org/10.1016/s0029-7844(03)00374-0CrossRef

Pickett CK, Regensteiner JG, Woodard WD et al (1989) Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 66(4):1656–1661. https://doi.org/10.1152/jappl.1989.66.4.1656CrossRef

10.

Manber R, Kuo TF, Cataldo N et al (2003) The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep 26(2):163–168

11.

Shahar E, Redline S, Young T et al (2003) Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 167(9):1186–1192. https://doi.org/10.1164/rccm.200210-1238OCCrossRef

12.

Keefe DL, Watson R, Naftolin F (1999) Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 6(3):196–200. https://doi.org/10.1097/00042192-199906030-00004CrossRef

13.

Lindberg E, Bonsignore MR, Polo-Kantola P (2020) Role of menopause and hormone replacement therapy in sleep-disordered breathing. Sleep Med Rev 49:101225. https://doi.org/10.1016/j.smrv.2019.101225CrossRef

14.

Carskadon MA, Dement WC, Mitler MM et al (1986) Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 9(4):519–524. https://doi.org/10.1093/sleep/9.4.519CrossRef

15.

Guileminault C, Stoohs R, Clerk AA et al (1993) A cause of excessive daytime sleepiness. The upper airway resistance syndrome. Chest 104:781–787. https://doi.org/10.1378/chest.104.3.78118CrossRef

16.

Maggard MD, Cascella M (2021) Upper airway resistance syndrome. In: StatPearls. StatPearls Publishing, Treasure Island

17.

Stoohs RA, Knaack L, Blum HC et al (2008) Differences in clinical features of upper airway resistance syndrome, primary snoring, and obstructive sleep apnea/hypopnea syndrome. Sleep Med 9(2):121–128. https://doi.org/10.1016/j.sleep.2007.02.010CrossRef

18.

Stoohs RA (2007) Upper airway resistance syndrome. Dtsch Arztebl 104(12):784–789

19.

Tufik SB, Pires GN, Palombini L et al (2022) Prevalence of upper airway resistance syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 91:43–50. https://doi.org/10.1016/j.sleep.2022.02.004CrossRef

20.

Mohsenin V (2001) Gender differences in the expression of sleep-disordered breathing: role of upper airway dimensions. Chest 120:1442–1447. https://doi.org/10.1378/chest.120.5.1442CrossRef

21.

Tantrakul V, Park CS, Guilleminault C (2012) Sleep-disordered breathing in premenopausal women: differences between younger (less than 30 years old) and older women. Sleep Med 13(6):656–662. https://doi.org/10.1016/j.sleep.2012.02.008CrossRef

22.

Orth M, Rasche K (2018) Sexualität bei obstruktivem Schlafapnoe-Syndrom. AT 44(9):1–26

23.

DEXIMED – Deutsche Experteninformation Medizin

24.

Liu L, Kang R, Zhao S et al (2015) Sexual dysfunction in patients with obstructive sleep apnea: a systematic review and meta-analysis. J Sex Med 12:1992–2003. https://doi.org/10.1111/jsm.12983CrossRef

25.

Steinke E, Palm Johansen P, Fridlund B et al (2016) Determinants of sexual dysfunction and interventions for patients with obstructive sleep apnoea: a systematic review. Int J Clin Pract 70(1):5–19. https://doi.org/10.1111/ijcp.12751CrossRef

26.

Giraldi A, Rellini A, Pfaus JG et al (2011) Questionnaires for assessment of female sexual dysfunction: a review and proposal for a standardized screener. J Sex Med 8(10):2681–2706. https://doi.org/10.1111/j.1743-6109.2011CrossRef

27.

Wiegel M, Meston C, Rosen R (2003) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. Sex Marital Ther 31(1):1–20. https://doi.org/10.1080/00926230590475206CrossRef

28.

Derogatis LR, Rosen R, Leiblum S et al (2002) The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 28(4):317–330. https://doi.org/10.1080/00926230290001448CrossRef

29.

Petersen M, Kristensen E, Berg S et al (2012) Sexual function in female patients with obstructive sleep apnea. J Sex Med 8(9):2560–2568. https://doi.org/10.1111/j.1743-6109.2011.02358.xCrossRef

30.

Köseoğlu N, Köseoğlu H, Itil O et al (2007) Sexual function status in women with obstructive sleep apnea syndrome. J Sex Med 4:1352–1357. https://doi.org/10.1111/j.1743-6109.2006.00302.xCrossRef

31.

Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571. https://doi.org/10.1001/archpsyc.1961.01710120031004CrossRef

32.

Kupperman HS, Blatt MH, Wiesbaden H et al (1953) Comparative clinical evaluation of estrogen preparations by the menopausal and amenorrhoeal indices. J Clin Endocrinol 13:688–703. https://doi.org/10.1210/jcem-13-6-688CrossRef

33.

Johns M (1993) Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 10(1):30–36. https://doi.org/10.1378/chest.103.1.30CrossRef

34.

Coelho G, Bittencourt L, Levy Andersen M et al (2021) Depression and obesity, but not mild obstructive sleep apnea, are associated factors for female sexual dysfunction. Sleep Breath 26(2):697–705. https://doi.org/10.1007/s11325-021-02433-wCrossRef

35.

Onem K, Erol B, Sanli O et al (2008) Is sexual dysfunction in women with obstructive sleep apnea-hypopnea syndrome associated with the severity of the disease? A pilot study. J Sex Med 5(11):2600–2609. https://doi.org/10.1111/j.1743-6109.2008.00934.xCrossRef

36.

Fanfulla F, Camera A, Fulgoni P et al (2013) Sexual dysfunction in obese women: does obstructive sleep apnea play a role? Sleep Med 14:252–256. https://doi.org/10.1016/j.sleep.2012.11.023CrossRef

37.

Yilmaz Z, Sirinocak PB, Voyvoda B et al (2017) Sexual dysfunction in premenopausal women with obstructive sleep apnea. Urol J 14(6):5051–5056. https://doi.org/10.22037/j.v14i6.3891CrossRef

38.

Metaclife M, Goldman E (1965) Validation of an inventory for measuring depression. Br J Psychiatry 111:240–242. https://doi.org/10.1192/bjp.111.472.240CrossRef

39.

Stavaras C, Pastaka C, Papala M et al (2012) Sexual function in pre- and post-menopausal women with obstructive sleep apnea syndrome. Int J Impot Res 24:228–233. https://doi.org/10.1038/ijir.2012.20CrossRef

40.

Clayton AH, McGarvey EL, Clavet GJ (1997) The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull 33(4):731–745

41.

Thompson JK, Schaefer LM, Cash TF (2019) A multidimensional innovator in the measurement of body image; some lessons learned and some lessons for the future of the field. Body Image 31:198–203. https://doi.org/10.1016/j.bodyim.2019.08.006CrossRef

42.

AHA medical/scientific statement (1994) Revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulatio 90(1):644–645

43.

Skoczyński S, Nowosielski K, Minarowski L et al (2020) Sexual disorders and dyspnoea among women with obstructive sleep apnea. Adv Med Sci 65(1):189–196. https://doi.org/10.1016/j.advms.2019.12.003CrossRef

44.

Beck AT, Epstein N, Brown G et al (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56(6):893–897. https://doi.org/10.1037//0022-006x.56.6.893CrossRef

45.

McGahuey CA, Gelenberg AJ, Laukes CA et al (2000) The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 26(1):25–40. https://doi.org/10.1080/009262300278623CrossRef

46.

Kabak M, Akbudak M (2021) Obstructive sleep apnea syndrome as a potential cause of sexual dysfunction in women. Sleep Breath 25(3):1511–1517. https://doi.org/10.1007/s11325-020-02275-yCrossRef

47.

Wikipedia

48.

Helvaci N, Karabulut E, Demir AU et al (2017) Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature. Endocr Connect 6(7):437–445. https://doi.org/10.1530/EC-17-0129CrossRef

49.

Torres-Zegarra C, Sundararajan D, Benson J et al (2021) Care for adolescents with polycystic ovary syndrome: development and prescribing patterns of a multidisciplinary clinic. J Pediatr Adolesc Gynecol 34(5):617–625. https://doi.org/10.1016/j.jpag.2021.02.002CrossRef

50.

Fogel RB, Malhotra A, Pillar G et al (2001) Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86(3):1175–1180. https://doi.org/10.1210/jcem.86.3.7316CrossRef

51.

Chatterjee B, Suri J, Suri JC et al (2014) Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome. Sleep Med 15(12):1547–1553. https://doi.org/10.1016/j.sleep.2014.06.023CrossRef

52.

Gopal M, Duntley S, Uhles M et al (2002) The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 3(5):401–404. https://doi.org/10.1016/s1389-9457(02)00033-3CrossRef

53.

Vgontzas AN, Legro RS, Bixler EO et al (2001) Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86(2):517–520. https://doi.org/10.1210/jcem.86.2.7185CrossRef

54.

De Sousa G, Schlüter B, Buschatz D et al (2010) A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents. Sleep Breath 14(1):33–38. https://doi.org/10.1007/s11325-009-0276-0CrossRef

55.

Mokhlesi B, Scoccia B, Mazzone T et al (2012) Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women. Fertil Steril 97(3):786–791. https://doi.org/10.1016/j.fertnstert.2011.12.024CrossRef

56.

Nandalike K, Strauss T, Agarwal C et al (2011) Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome. J Pediatr 159(4):591–596. https://doi.org/10.1016/j.jpeds.2011.04.027CrossRef

57.

Nandalike K, Agarwal C, Strauss T et al (2012) Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Med 13(10):1307–1312. https://doi.org/10.1016/j.sleep.2012.07.002CrossRef

58.

Yang HP, Kang JH, Su HY et al (2009) Apnea-hypopnea index in nonobese women with polycystic ovary syndrome. Int J Gynaecol Obstet 105(3):226–229. https://doi.org/10.1016/j.ijgo.2009.02.004CrossRef

59.

Lin TY, Lin PY, Su TP et al (2017) Risk of developing obstructive sleep apnea among women with polycystic ovarian syndrome: a nationwide longitudinal follow-up study. Sleep Med 36:165–169. https://doi.org/10.1016/j.sleep.2016.12.029CrossRef

60.

Kumarendran B, Sumilo D, O’Reilly MW et al (2019) Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study. Eur J Endocrinol 180(4):265–272. https://doi.org/10.1530/EJE-18-0693CrossRef

Titel: Schlafbezogene Atmungsstörungen und Gynäkologie – Teil 2
Therapie, Sonderformen von SBAS bei Frauen, Auswirkungen von SBAS auf die Sexualfunktion bei Frauen, Syndrom der polyzystischen Ovarien
verfasst von: Prof. Dr. med. M. Orth
K. Rasche
Publikationsdatum: 01.12.2022
Verlag: Springer Medizin
Schlagwörter: Polyzystisches Ovarialsyndrom
Hormonsubstitution
Polyzystisches Ovarialsyndrom
Schlafbezogene Atmungsstörung
Obstruktives Schlafapnoesyndrom
Polysomnografie
Östrogene
Progesteron
Erschienen in: Somnologie / Ausgabe 4/2022
Print ISSN: 1432-9123
Elektronische ISSN: 1439-054X
DOI: https://doi.org/10.1007/s11818-022-00384-2

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2022

Konsensus-Statement der Österreichischen Gesellschaft für Schlafmedizin (ÖGSM/ASRA) zum Management der residualen exzessiven Tagesschläfrigkeit (rETS) bei obstruktiver Schlafapnoe

Sleep in German female youth national ice hockey athletes

Videospiele und Schlaf – negativer Zusammenhang oder unbedenkliches Zocken?

Wirkmechanismen körperlicher Aktivität auf den Schlaf bei Patienten mit Depression: Ein Narratives Review

Schlafqualität und kardialer autonomer Tonus bei Leistungssporttreibenden und in einer Referenzgruppe Gesunder

Nachruf Prof. Dr. Karl Hecht